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(Director: Prof. Dr. Haruhiko KIKUCHI) 
Recent reports suggest that protein phosphorylation is involved in neural differentiation. We have 
found that specific inhibitors of protein phosphorylation at tyrosine residues, Erbstatin, Genistein, Her-
bimycin A, effectively induce neural differentiation in a human neuroblastoma cel line SK-N-DZ and a 
human medulloblastoma cel line Med-3, as indicated by the marked increase in the number of 
neurites/cel and in the expression of neurofilaments (160 k) detected by immunohistochemical studies. 
Possible involvement of protein phosphorylation at tyrosine residues in the differentiation of neural tumor 
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Table 1 Morphological changes in human neuroblastoma cel lines GOTO, SK-N-DZ and a human glioblastoma 
cel line T98G and a human medulloblastoma cel line Med 3 induced by additions of Erbstatin (3 μglml), 
Genistein (3 μglml), Vanadate (10 μM) and Herbimycin A (0.5 μM) 
Erbstatin Genistein Vanadate Herbimycin A 
GOTO ＋ ？ ＋ . ＋→ 
SK-N-DZ ＋＋け 十十 ti ＋→ 
T98G 
恥1ed-3 ＋ ＋ . ＋ . 
Elongation of neurites: , none; +, slight (10%-30%); + +, moderate (30%-50%); + + ,marked (50%-80%) 

































Erbstatin, Genistein: 3 μg/ml 
Herbimycin A: 0.5 μg/ml 
Vanadate: 10 μM (Fig. 1) 
物 pp60v・mおよび Epidermalgrowth factor receptor 3) 分化誘導の指標
tyrosine kinase inhibitor 
Erbstatin ← Streptomyces 
Genistein ← Pseudomonas 
Herbimycin A ← Streptomyces 
tyrosine phosphatase inhibitor 
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Fig. 1 Tyrosine kinase inhibitors/origins and structures. Tyrosine phosphatase inhibitor/origin 
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Table 2 Induction of in vitro differentiation. 
erythroleukemia [hemoglobin] 
(mouse MEL) 
DMSO, HMBA; Genistein, Herbimycin A 
embryonal carcinoma [plasminogen activator, laminin, SSEA-1] 
(mouse F9) RA, ( +) Bt2c-AMP; Herbimycin A 
neuroblastoma [ neu ro制ament]
(human SK-N-DZ) 
RA, Bt2c-AMP; Genistein, Herbimycin A 
Erbstatin 
medulloblastoma [neurofilament, GFAP] 
(human Med-3) 
cel lines [markers] inducers 
DMSO: Dimethyl sulfoxide 
HMBA: Hexamethylenebisacetamide 
SSEA-1: stage-specific embryonic antigen-1 
RA: retinoic acid 
Bt2c-AMP：・ dibutyrylcyclic AMP 
GFAP: Glial fibrillary acidic protein 
Genistein, Herbimycin A 
Erbstatin 









Fig. 2 Morphological alteration of a neuroblastoma cel line SK-N-DZ treated with several drugs for 3 days 
E: Erbstatin (3 μg/ml), G: Genistein (3 μg/ml), V: Vanadate (10 μM) 
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基礎実験の結果より，薬剤添加培養後3日目に，形 が注目されている即1,27）.ヒト髄芽腫由来株 Med-3細
態学的変化が最も著明であったので、この day3に，ニ 胞の，上記薬剤の分化誘導における N-myc夕、ノパク
ユーロン系の分化抗原 neurofilament(160 kDa）の発現 の発現変化を薬剤添加培養後 day3に， antihuman N-
量の変化を， anti-human160 k neurofilament antibody myc polyclonal antibody （ニチレイ社）をもちいて
(Immunotech社）をもちいて，免疫組織化学染色22）と Western blotting assayにて調べた．
Western blotting assayにて調べたーまたニューロン系 4) チロシンリン酸化タンパクの発現
とグリア系への bipotentialな分化能を有するとされる チロシンリン酸化酵素阻害剤が細胞内で正しくその
髄芽腫の由来株 Med-3細胞には，グリア系の分化抗 機能を働かせている事を確認する目的で， SK-N-DZ
原 Glialfibrillary acidic protein (GFAP）の発現25）を併 細胞と Med-3細胞ともに薬剤添加培養後day3に，阻ー
せて調べたー ti-phosphotyrosine monoclonal antibody (Boehringer社）




















来株である T98G 細胞は Erbstatin, Genistein, 
Vanadate のいずれにも反応しなかった．一方髄芽腫








DZ 細胞では発現増大が観察され（Fig. 4), また









PC DZ +E1 3 
Fig. 5 Expres on of neuro且lament(160 kDa) in E r b 
statin, Genistein-treated or untreated SK-N-
DZ cells and untreated rat Pheochromocytoma 
cells by Western blot analysis. Im 
munoprecipitates were electrophoresed on 10% 
sodium dodecyl sulfate-polyacrylamide gel, 
transferred onto nitrocellulose membranes, and 
analyzed with anti-neurolilaments monoclonal 
antibody. 
Erb 
._:; .;-tJ ・E 、’L 
Gen 
Van. 
Fig. 4 Immunohistochemical staini時 ofSK-N-DZ (anti human neurofilaments antibody, ABC methods) treated 
with drugs for 3 days. 







Fig. 6 Immunohistochemical staining of Med-3 (anti-human neurofilaments antibody and anti-human GFAP an-
tibody, ABC methods) untreated or treated with drugs for 3 days. 
NF: neurofilament, GFAP: glial fibrillary acidic protein, E: Erbstatin, H: Herbimycin A 
あった.(Fig. 6) 
3) N-mycタンパクの発現
Western blotting assayによる Nmycタンパクの発


















+ E G H 
Fig. 7 Expression of N-myc gene product in tyrosine 
kinase inhibitors-treated or untreated恥1ed-3
cells by Western blot analysis. E: Erbstatin, 







SR DZ +E G 
Fig. 8 Expression of tyrosine-phosphorylated proteins 
in Erbstatin, Genistein-treated or untreated 
SK-N-DZ cells by immunoprecipitation. DZ: 
untreated SK-N-DZ cells, SR: Rous sarcoma 






+E G H 
Fig. 9 Expression of tyrosine-phosphorylated proteins 
in Erbstatin, Genistein叩treatedor untreated 
Med-3 cels by immunoprecipitation. DZ: un-
treated SK-N-DZ cels, SR: Rous sarcoma 

























来培養細胞あるいはヒト 白血病細胞を HerbimycinA 
や Genistein にて分化誘導したというものがあ
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